Joe Truitt, CEO of iECURE, discusses his company’s in vivo gene editing therapies, its focus on liver diseases, and how it’s leveraging its partnership with the University of Pennsylvania’s Gene Therapy Program.

Developing in Vivo Gene Editors that Target Liver Diseases

<p>RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy. </p>

Business

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Share Developing in Vivo Gene Editors that Target Liver Diseases

Sign up to save your podcasts

Developing in Vivo Gene Editors that Target Liver Diseases

Developing in Vivo Gene Editors that Target Liver Diseases